Favipiravir Induced Acute Pancreatitis in a COVID-19 Patient

There are a number of gastrointestinal symptoms and complications COVID-19. Asymptomatic increase in pancreatic enzymes rarely symptomatic pancreatitis observed this disease. This article describes 37-year-old male suffering from mildly COVID-19 infection, who received tablet favipiravir for his management. His condition was improving, when he developed acute pancreatitis, diagnosed clinically, biochemically also with help abdominal ultrasound. When this, all typical were improved. As result, role the development suspected.
 J MEDICINE JAN 2021; 22 (1) : 69-71